Search Results 2671-2680 of 17721 for rheumatoid arthritis

  1. Virotherapy Clinical Trials - Mayo Clinic Research

    The purpose of this study is to look at the safety and immune response to a vaccine used in patients previously treated for HER2 (human epidermal growth factor ...

  2. A Study to Evaluate the Effectiveness and Safety of rAd-IFN Administered With Celecoxib and Gemcitabine in Patients With Malignant Pleural Mesothelioma - Mayo Clinic

    Hematopoietic growth factor, at least 14 days from last dose; or; Study drug, 30 days or 5 half-lives, whichever is longer, from last dose. Patient ...

  3. Serial Blood and Urine Monitoring Study in Kidney Transplant Recipients - Mayo Clinic

    ... factor FOXP3, combined with a second marker for CD4 or CD8. Quantitative FOXP3 cell counts were performed and analyzed for clinical and pathologic ...

  4. S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma - Mayo Clinic

    ... factor support within 14 days prior to registration; Platelets >= 50,000 cells/mm^3 for patients who have bone marrow plasmacytosis < 50% or >= 30,000 cells ...

  5. Publications - Sujay A. Vora, M.D. - Mayo Clinic

    Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade >/= 2 Rectal Toxicity in Patients Treated for Prostate ...

  6. A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma - Mayo Clinic

    ... factor support, or medically significant need for intervention. For subjects with presumptive evidence of transformation based on clinical assessment of ...

  7. A Study to Evaluate Safety of Enapotamab Vedotin in Patients with Solid Tumors - Mayo Clinic

    Have received granulocyte colony stimulating factor (G-CSF) or granulocyte/macrophage colony stimulating factor support 3 weeks prior to first enapotamab ...

  8. Publications - Scott H. Okuno, M.D. - Mayo Clinic

    Recent advances and optimal management of human epidermal growth factor receptor-2-positive early-stage breast cancer. J Carcinog. 2019; 18:5 Epub 2019 Dec ...

  9. Physical Medicine and Rehabilitation - Doctors - Mayo Clinic

    Wenchun Qu, M.D., Ph.D. Physiatrist. Jacksonville, FL. Areas of focus: Regenerative medicine therapy, Ultrasound, Pain management, Back pain, Arthritis, Neck ...

  10. Clinical trials - Oncology (Medical)

    ... factor receptor 2 negative (ER+/HER2-) advanced or metastatic breast cancer that has progressed on treatment with everolimus in combination with exemestane ...